Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.670
-0.090 (-1.89%)
At close: Aug 10, 2026, 4:00 PM EDT
4.580
-0.090 (-1.93%)
After-hours: Aug 10, 2026, 7:34 PM EDT
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $45.38M in the quarter ending June 30, 2026, a decrease of -4.24%. This brings the company's revenue in the last twelve months to $205.31M, down -3.95% year-over-year. In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth.
Revenue (ttm)
$205.31M
Revenue Growth
-3.95%
P/S Ratio
1.48
Revenue / Employee
$456,238
Employees
450
Market Cap
302.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 212.69M | 3.33M | 1.59% |
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | 39.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 301.61M |
| Pacific Biosciences of California | 159.27M |
| InfuSystem Holdings | 143.34M |
| RxSight | 127.58M |
| Standard BioTools | 84.60M |
| Electromed | 71.75M |
| 908 Devices | 57.80M |
| TriSalus Life Sciences | 45.08M |
TMCI News
- 3 days ago - Treace Medical Concepts Earnings Call Transcript: Q2 2026 - Transcripts
- 3 days ago - Treace Medical Concepts Earnings release: Q2 2026 - Filings
- 3 days ago - Treace Medical Concepts Quarterly report: Q2 2026 - Filings
- 3 days ago - Treace Medical Concepts Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 17 days ago - Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 17 days ago - Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 - GlobeNewsWire
- 25 days ago - Treace Medical price target raised to $4 from $2 at Truist - TheFly
- 4 weeks ago - Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI) - GlobeNewsWire